SATURN: High-Intensity Statin Therapy May Induce Diabetic Coronary Atherosclerosis Regression

Benefits of Extended-Release Niacin Questionable
Benefits of Extended-Release Niacin Questionable
Patients with diabetes may experience regression of coronary atherosclerosis with high-intensity statin therapy.

Although statins can induce coronary atheroma regression, this benefit has yet to be demonstrated in diabetic individuals. We tested the hypothesis that high-intensity statin therapy may promote coronary atheroma regression in patients with diabetes.

READ FULL ARTICLE Curated publisher From Diabetesjournals